Fig. 1: Impact of the synthetic androgen R1881 on prostate-specific antigen (PSA) production of prostate cancer cell lines. | npj Systems Biology and Applications

Fig. 1: Impact of the synthetic androgen R1881 on prostate-specific antigen (PSA) production of prostate cancer cell lines.

From: Evaluating PSA dynamics for predicting androgen deprivation failure with a patient specific prostate cancer model

Fig. 1

Prostate cancer cells C4-2B (a) and LNCaP (b) were treated in triplicates with R1881 at a final concentration of 0, 0.1, 1, and 10 nM. Forty-eight hours after treatment with R1881, conditioned media was harvested and measured for PSA by ELISA, and the cells were harvested and counted. Data shows the means ± SEM, * denotes p value < 0.05 versus LNCaP 0.1 nM.

Back to article page